3Perzborn E,Strassburger J,W ilmen A,et al.In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral direct factor Xa inhibitor[J].J Thromb Haemost,2005,3(3):514-521.
4Kuhitza D,Becka M,Voith B,et al.Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct Factor Xa inhibitor[J].Clin Pharmacol Ther,2005,78(4):412-421.
5Kakkar AK,Brenner B,Dahl OE,et al.Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboambolism after total hip arthroplasty:a doubleblind,randomised controlled trial[J].Lancet,2008,372:31-34.
6Lassen MR,Ageno W,Borris LC,et al.Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty[J].N Engl J Med,2008.358(26):2776-2779.
二级参考文献9
1De Gregorio MA,Gimeno MJ,Mainar A,et al.Mechanical and enzymatic thrombolysis for massive pulmonary embolism.J Vasc Interv Radiol,2002,13:163-169.
2Stein PD,Afzal A,Henry JW,et al.Fever in acute pulmonary embolism.Chest,2000,117:39-42.
3Miniati M,Prediletto R,Formichi B,et al.Accuracy of clinical assessment in the diagnosis of pulmonary embolism Am J Respir Crit Care Med,1999,159:864-871.
4Aburahma AF,Saiedy S.Deep vein thrombosis as a probable cause of fever of unknown origin.W V Med J,1997,93:368-370.
5Stallman JS,Aisen PS,Aisen ML.Pulmonary embolism presenting as fever in spinal cord injury patients:report of two cases and review of the literature.J Am Paraplegia Soc,1993,16:157-159.
5Wells PS, Hirsh J, Anderson DR,et al. Accuracy of clinical assesment of deep - vein thrombosis [ J ]. Lancet, 1995,8961 : 1326 - 1304.
6Oudega R, Hoes AW, Moons KG. The Wells rule does not adequately rule out deep venous thrombosis in primary care patients[ J]. Ann Intern Med ,2005,2 : 100 - 107.
7Stevens SM,Ageno W. The Wells rule was not useful in ruling out deep venous thrombosis in primary care setting[J]. Evid Based Med,2006,2: 57.
8Ebell MH. Evaluation of the patient with suspected deep vein thrombosis[J]. Faro Pract ,2001,1:16 -17.
9Ridker PM, Miletich JP, Stampfer MJ, et al. Factor V leiden and risk of recurrent idiopathic venous thromboembolism [ J ]. Circulation, 1995,10 : 2800 - 2802.
10Knaus WA, Draper EA, Wagner DP,et al. APACHI/2:a severity of disease classificalion system[J]. Cril Care Med,1985,10:818 -829.
